You are here

FSD Pharma Inc. Subordinate Voting Shares

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
HUGE
CSE Index: 
Currency: 

FSD Pharma is targeting all legal aspects of the cannabis industry, including cultivation, processing, manufacturing, extracts and research and development.

FSD is a licensed producer of cannabis under the Cannabis Act. The Company received its cultivation license on October 13, 2017. An amendment to the licence effective November 8, 2018, allows the Company to sell cannabis to other licensed producers. On February 19, 2019, the Company received its Standard Processing License, which is required for any facility that is processing more than the equivalent of 600 kg of dried flowers per year.

FSD is a science driven company with a mission to leverage the largest hydroponic indoor cannabis facility in the world to research and develop life-saving medicines based on cannabinoid science.

FSD is planning for a stage-phased development at its primary location in Cobourg, Ontario. Currently, the Company has 25,000 square feet of grow space available. Once completed, the facility is expected to have 3,800,000 sq. ft. of cultivation and related ancillary businesses.

You are here

FSD Pharma Inc. Subordinate Voting Shares (HUGE)

SEDAR Information

Company Info

Address
520 William Street
Cobourg, ON K9A 3A5
Canada
Phone
(289) 677-0806
Fax
(905) 373-0303
Email
info@fvpharma.com
Website
http://www.fsdpharma.com
Listing date
Tuesday, May 29, 2018
Transfer Agent
Computershare Investor Services Inc.
Investor Relations
Sandra Huard
Email
sandralhuard@gmail.com
Auditor
UHY McGovern Hurley LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
7,874,809
Reserved for Issuance: 
1,610,281

Company Officers

Dr. Raza Bokhari, Chief Executive Officer and Co-Chairman - FSD Pharma Inc.
Anthony Durkacz, Co-Chairman - FSD Pharma Inc.
Zeeshan Saeed, President - FSD Pharma Inc.
Donal Carroll, Chief Financial Officer
Dr. Sara May, President - FV Pharma Inc.

Bulletins

11/10/2019

2019-1006 – Consolidation - FSD Pharma Inc. Subordinate Voting Shares (HUGE)

le 11 octobre/October 2019

FSD Pharma Inc. has announced a consolidation of its Class B Subordinate Voting shares on the basis  of one (1) post-consolidation common share for every two hundred one (201) pre-consolidation common shares.

As a result, the outstanding shares of the company will be reduced to approximately 7,874,809.

The shares will begin trading on a consolidated basis and with a new CUSIP number on October 16, 2019.

The name and symbol will not change.

Advertisement

Publicité

Latest CSE News

Upcoming Events

11_12_Northwind_Forum_Website

Northwind’s 13th Annual Capital Markets Invitational Forum

Tuesday, November 12, 2019 (All day) to Wednesday, November 13, 2019 (All day)
11_12_2nd_Annual_Boston_Cannabis_Conference_Website

2nd Annual Boston Cannabis Conference

Tuesday, November 12, 2019 (All day) to Wednesday, November 13, 2019 (All day)